Argomenti e Notizie
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Anno 20°
Num. 127
Recens. 2460
Aderiamo allo standard HONcode per l'affidabilità dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
Nuova bibliografia selezionata fino al mese di luglio 2015 (recensioni 26) Ordina per Autore - Titolo - Rivista
Bonaccorsi G, Fila E, Cervellati C, Romani A, Giganti M, Rossini M, Greco P, Massari L.
Assessment of Fracture Risk in A Population of Postmenopausal Italian Women: A Comparison of Two Different Tools.
Calcif Tissue Int. 2015 Jul;97(1):50-7.

Doroudinia A, Colletti PM.
Bone Mineral Measurements.
Clin Nucl Med. 2015 Aug;40(8):647-57.

Licata AA.
Challenges of Estimating Fracture Risk with DXA: Changing Concepts About Bone Strength and Bone Density.
Aerosp Med Hum Perform. 2015 Jul;86(7):628-32.

Colón-Emeric C, Pieper CF, Grubber J, Van Scoyoc L, Schnell ML, Van Houtven CH, Pearson M, Lafleur J, Lyles KW, Adler RA.
Correlation of Hip Fracture with Other Fracture Types: Toward a Rational Composite Hip Fracture Endpoint.
Bone. 2015 Jul 4.

Krueger D, Libber J, Sanfilippo J, Yu HJ, Horvath B, Miller CG, Binkley N. A
DXA Whole Body Composition Cross-Calibration Experience: Evaluation With Humans, Spine, and Whole Body Phantoms.
J Clin Densitom. 2015 Jun 9. pii:S1094-6950(15)00041-4.

Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie SM.
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
Lancet. 2015 Jul 2. pii: S0140-6736(15)61120-5.

Cheung MS.
Drugs Used in Paediatric Bone and Calcium Disorders.
Endocr Dev.2015;28:277-90.

Ruggiero C, Zampi E, Rinonapoli G, Baroni M, Serra R, Zengarini E, Baglioni G, Duranti G, Ercolani S, Conti F, Caraffa A, Mecocci P, Brandi ML.
Fracture prevention service to bridge the osteoporosis care gap.
Clin Interv Aging. 2015 Jun 25;10:1035-1042.

Goldenstein PT, Jamal SA, Moysés RM.
Fractures in chronic kidney disease: pursuing the best screening and management.
Curr Opin Nephrol Hypertens. 2015 Jul;24(4):317-23.

De Melo TG, Da Assumpção LV, Santos Ade O, Zantut-Wittmann DE.
Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma.
Thyroid Res. 2015 Jun 2;8:7.

Hofbauer LC, Rachner TD.
More DATA to guide sequential osteoporosis therapy.
Lancet. 2015 Jul 2. pii: S0140-6736(15)61175-8.

Boggild MK, Gajic-Veljanoski O, McDonald-Blumer H, Ridout R, Tile L, Josse R, Cheung AM.
Odanacatib for the treatment of osteoporosis.
Expert Opin Pharmacother. 2015 Jul 6:1-10.

Weaver CM.
Parallels between nutrition and physical activity: research questions in development of peak bone mass.
Res Q Exerc Sport. 2015 Jun;86(2):103-6.

Mow TC, Stokes CM, Sutherland AG.
Patients presenting with fractures are likely to be vitamin D deficient: are we getting enough sun?
ANZ J Surg. 2015 May 26.

Wang CC, Wu CH, Farley JF.
Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.
Ann Pharmacother. 2015 Jun 3. pii: 1060028015588127.

Hadji P, Papaioannou N, Gielen E, Feudjo Tepie M, Zhang E, Frieling I, Geusens P, Makras P, Resch H, Möller G, Kalouche-Khalil L, Fahrleitner-Pammer A.
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Osteoporos Int. 2015 May 28.

Said CM, Batchelor F, Shaw K, Blennerhassett J.
Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines?
Geriatr Gerontol Int. 2015 May 15.

Yu J, Brenneman SK, Sazonov V, Modi A.
Reasons for not initiating osteoporosis therapy among a managed care population.
Patient Prefer Adherence. 2015 Jun 19;9:821-30.

Ferlin A, Selice R, Di Mambro A, Ghezzi M, Di Nisio A, Caretta N, Foresta C.
Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
Osteoporos Int. 2015 May 12. d

El-Hajj Fuleihan G, Bouillon R, Clarke B, Chakhtoura M, Cooper C, McClung M, Singh RJ.
Serum 25-Hydroxyvitamin D Levels: Variability, Knowledge Gaps, and the Concept of a Desirable Range.
J Bone Miner Res. 2015 Jul;30(7):1119-33.

Woodward MJ, Lu CW, Levandowski R, Kostis J, Bachmann G.
The exercise prescription for enhancing overall health of midlife and older women.
Maturitas. 2015 Apr 8.

Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C.
Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
J Craniomaxillofac Surg. 2015 Jul;43(6):847-54.

Ruutiainen AT.
Utilization and Reporting of Bone Densitometry: What Can the Musculoskeletal Radiologist Do to Help, Rather Than to Hurt?
Acad Radiol. 2015 Jun 18. pii: S1076-6332(15)00080-X.

Uenishi K.
[Bone and Nutrition. Calcium intake and bone health].
Clin Calcium.2015;25(7):959-66.

Camporro F, Redondo L, Bulacio E, Gutiérrez Magaldi I, Chamale E, Sáenz F.
[Comparison of FRAX Score without bone mineral density determination and the criteria proposed by the Argentine Osteoporosis Society for the use of antiresorptive therapy in postmenopausal women].
Medicina (B Aires). 2015;75(3):155-8.

Moro Álvarez MJ, Neyro JL, Castañeda S.
[Therapeutic holidays in osteoporosis: Long-term strategy of treatment with bisphosphonates].
Med Clin (Barc). 2015 Jun 2. pii: S0025-7753(15)00256-0.

(Vers. 2.1)  Modificato il 9-7-2015   
questo sito aderisce ai principi HONCODE    disclaimer